Clinical Outcomes of patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with nab-paclitaxel + carboplatin (nab-P/C) and solvent-based paclitaxel + carboplatin (sb-P/C) stratified by age and renal function: a retrospective analysis of a phase III trial.

Eric Bernicker; Mark A. Socinski; Amy Ko; Teng Jin Ong; Corey J. Langer

doi:10.1200/jco.2015.33.15_suppl.e19020

Clinical Outcomes of patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with nab-paclitaxel + carboplatin (nab-P/C) and solvent-based paclitaxel + carboplatin (sb-P/C) stratified by age and renal function: a retrospective analysis of a phase III trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e19020 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e19020-e19020

Author(s):

Eric Bernicker ◽

Mark A. Socinski ◽

Amy Ko ◽

Teng Jin Ong ◽

Corey J. Langer

Keyword(s):

Lung Cancer ◽

Renal Function ◽

Small Cell Lung Cancer ◽

Retrospective Analysis ◽

Clinical Outcomes ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2010.02.011 ◽

2010 ◽

Vol 70 (3) ◽

pp. 340-346 ◽

Cited By ~ 10

Author(s):

Joseph Treat ◽

Martin J. Edelman ◽

Chandra P. Belani ◽

Mark A. Socinski ◽

Matthew J. Monberg ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Retrospective Analysis ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Histological Subgroups

Download Full-text

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial

Drug Design Development and Therapy ◽

10.2147/dddt.s155750 ◽

2018 ◽

Vol Volume 12 ◽

pp. 1445-1451 ◽

Cited By ~ 2

Author(s):

Cesare Gridelli ◽

Tianlei Chen ◽

Amy Ko ◽

Mary E O'Brien ◽

Teng Jin Ong ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Retrospective Analysis ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

6521 POSTER Is pemetrexed more effective in patients with non-squamous histology? A retrospective analysis of a phase III trial of pemetrexed vs docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71349-6 ◽

2007 ◽

Vol 5 (4) ◽

pp. 363-364 ◽

Cited By ~ 21

Author(s):

P. Peterson ◽

K. Park ◽

F. Fossella ◽

U. Gatzemeier ◽

W. John ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Retrospective Analysis ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Previously Treated Patients ◽

Previously Treated

Download Full-text

A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2010.03.003 ◽

2011 ◽

Vol 78 (2) ◽

pp. 162-171 ◽

Cited By ~ 33

Author(s):

Rafat H. Ansari ◽

Mark A. Socinski ◽

Martin J. Edelman ◽

Chandra P. Belani ◽

René Gonin ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Retrospective Analysis ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non[ndash ]small cell lung cancer

Seminars in Oncology ◽

10.1053/sonc.2001.24366 ◽

2001 ◽

Vol 28 (2D) ◽

pp. 7-10

Author(s):

Pasquale Comella

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)

BioDrugs ◽

10.1007/s40259-021-00489-4 ◽

2021 ◽

Author(s):

Konstantinos Syrigos ◽

Istvan Abert ◽

Zoran Andric ◽

Igor N Bondarenko ◽

Mikhail Dvorkin ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text

Randomized Phase III Trial of Dose-Dense Chemotherapy Supported by Whole-Blood Hematopoietic Progenitors in Better-Prognosis Small-Cell Lung Cancer

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/dji114 ◽

2005 ◽

Vol 97 (9) ◽

pp. 666-674 ◽

Cited By ~ 55

Author(s):

Paul Lorigan ◽

Penella J. Woll ◽

M. E. R. O'Brien ◽

Linda F. Ashcroft ◽

Mark R. Sampson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Whole Blood ◽

Small Cell ◽

Phase Iii ◽

Hematopoietic Progenitors ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Dose Dense

Download Full-text

Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2004.01.055 ◽

2004 ◽

Vol 59 (4) ◽

pp. 943-951 ◽

Cited By ~ 121

Author(s):

Steven E. Schild ◽

James A. Bonner ◽

Thomas G. Shanahan ◽

Burke J. Brooks ◽

Randolph S. Marks ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Long Term Results ◽

Small Cell Lung ◽

Once Daily ◽

Phase Iii Trial

Download Full-text

Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial Data

Journal of Oncology Practice ◽

10.1200/jop.1.2.37 ◽

2005 ◽

Vol 1 (2) ◽

pp. 37-42 ◽

Cited By ~ 2

Author(s):

M. R. Green ◽

M. Andrews ◽

R. Leff ◽

J. Willey ◽

C. Allegra ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Trial Data ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Treatment Plans

Download Full-text

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2017.05.037 ◽

2017 ◽

Vol 83 ◽

pp. 302-312 ◽

Cited By ~ 8

Author(s):

David Ferry ◽

Lucinda Billingham ◽

Hugh Jarrett ◽

David Dunlop ◽

Penella J. Woll ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Oncology Group ◽

Small Cell Lung ◽

Phase Iii Trial

Download Full-text